“These results establish the CssDNA process as an efficient non-viral gene insertion strategy, and mark a pivotal advance towards the development of next-generation cell and gene therapies” said ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

Cone rod dystrophy is a rare inherited retinal disorder impacting cones and rods, leading to progressive vision loss. The market for cone rod dystrophy is poised for growth due to rising disease ...

YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...

Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today announced the appointment of ...

Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds.

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.